Apr 14, 2015, 00:00
by
Michael Croft
ROCHESTER, NY - Apr 14, 2015 - The team behind Clinical Conductor CTMS recently debuted new functionality that allows healthcare organizations to better manage adaptive and dynamic clinical research that is becoming more relevant in the industry every year
Clinical Conductor CTMS
ROCHESTER, NY - Apr 14, 2015 - The team behind Clinical
Conductor CTMS recently debuted new functionality that allows
healthcare organizations to better manage adaptive and dynamic
clinical research that is becoming more relevant in the industry
every year. Included in this quarters release is functionality
that lets users create snapshots of past budgets to be used for
better negotiations and invoicing, the ability for organizations to
create multiple charge masters, and functionality that provides
better handling of protocol amendments. When added into the
existing functionality of Clinical Conductor, users are afforded
the unique opportunity to track and manage their complex and
changing research with an unparalleled level of granularity.
With budget snapshots, researchers are able to create multiple
versions of a studys budget within Clinical Conductor. This gives
users the ability to utilize historical budgets during negotiations
with sponsors and CROs, track budget changes as a study progresses
and keep better historical records that can be referenced during a
post-study analysis or for future study preparation. With budget
snapshots, the clearer financial picture allows organizations to
maximize study budget utilization benefits.
The ability to create and manage multiple charge masters within
Clinical Conductor allows organizations to manage complex billing
requirements for trials that occur at multiple locations or over a
long period of time. In the system, users can now reference
multiple charge masters for each study, accounting for the location
and time-period in which a procedure was conducted. As yearly cost
updates are implemented, they are easily incorporated into ongoing
studies, yielding greater accuracy in the assessment of the
profitability of an individual study or an entire organization.
Whats more, multiple charge masters make it easier to
differentiate between grant and industry funding.
Clinical Conductor is also fitted with advanced protocol
management functionality. Already the leading CTMS vendor in the
industry, the added protocol functionality lets users more easily
handle protocol amendments, create multiple versions of protocols
and tie them directly to specific patients, ensuring subjects
receive the correct procedures at all times. Researchers
managing both oncology and long-term observational studies also
benefit from the ability to manage investigator-initiated protocols
more effectively.
As research becomes more complex, and organizations partner or
consolidate, businesses constantly look for ways to overcome the
changing hurdles that inevitably occur during the study process,
and technology is steadily becoming the solution to these hurdles,
stated Bio-Optronics VP and COO Jeff Markin. Beyond that, of any
other CTMS application, Clinical Conductor continually advances
evolves to provide research organizations with flexible trial
management functionality that allows them to conduct studies with
relative ease in a compliant, profitable manner.
About Clinical Conductor CTMS
Clinical Conductor is the industrys first collaborative and
configurable CTMS for organizations managing or executing clinical
trials. Created by Bio-Optronics, an industry-leading provider of
software and services to healthcare and life sciences organizations
around the world, Clinical Conductor provides users with the
specific features and functionality they need to effectively
collaborate with or among sites and other partners, deliver
high-quality research and maximize profitability. Used by over
1,700 organizations around the world, Clinical Conductor provides
organizations with the tools they need to continue to raise the bar
in clinical research. To learn more about Clinical Conductor
CTMS, please visit
our website.